Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. [electronic resource]
- Breast cancer research : BCR 2011
- 224 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Review
1465-542X
10.1186/bcr3039 doi
Animals Antineoplastic Agents--therapeutic use Breast Neoplasms--drug therapy Disease Progression Enzyme Inhibitors--therapeutic use Female Humans Mutation Phosphatidylinositol 3-Kinases--genetics Receptor, ErbB-2--genetics Receptors, Estrogen--genetics Receptors, Progesterone--genetics Signal Transduction--drug effects